User: Genecampaign Topic: IP
Category: patents :: everywhere
Last updated: Oct 26 2014 06:35 IST RSS 2.0
 
7,454 to 7,473 of 9,592    
Ranbaxy shares fall 7% on Lipitor settlement with Pfizer 19.6.2008 Financial Express: Front Page
Shares of Ranbaxy Laboratories Ltd, which on Wednesday said it has settled most of its patent litigations on Pfizer Inc's blockbuster drug Lipitor, fell 7.68% on Thursday on the Bombay Stock Exchange, after the settlement was seen as offering no near-term benefit for the Indian company.
Also found in: [+]
Cipla, Ranbaxy at bottom in top 20 pharma firms survey 19.6.2008 Financial Express: Front Page
The domestic pharma majors, Cipla and Ranbaxy, have ranked at number 16 and 17 respectively among the 20 international pharma companies that were evaluated by the Netherlands-based "Access to Medicine Index" for the year, 2008.
Also found in: [+]
Online auction offers Indian IP a global market 19.6.2008 Financial Express: Front Page
In a first for India that could transform the outlook towards intellectual property transactions in the country, Bangalore will host a live simulcast later this month of a unique auction to be held in Amsterdam: that of IP assets in different categories.
Also found in: [+]
Pfizer, Ranbaxy deal would delay Lipitor 19.6.2008 Financial Express
Pfizer, Ranbaxy deal would delay Lipitor
Also found in: [+]
International Dog-Fight over cloning rights between BioArts International & RNL Bio 19.6.2008 Financial Express
International Dog-Fight over cloning rights between BioArts International & RNL Bio
Also found in: [+]
Ranbaxy slips 7% after Lipitor deal 19.6.2008 Financial Express
Ranbaxy slips 7% after Lipitor deal
Also found in: [+]
Mkts deep in red, Sensex sheds 338 pts 19.6.2008 Financial Express
Mkts deep in red, Sensex sheds 338 pts
Also found in: [+]
Ranbaxy, Pfizer settle patent litigation over Lipitor  19.6.2008 Central Chronicle
Ranbaxy, Pfizer settle patent litigation over Lipitor 
Also found in: [+]
Indian firm counts Lipitor gain 19.6.2008 Telegraph: Business
Mumbai, June 18: Ranbaxy Laboratories stands to rake in at least $1.5 billion once it starts selling the generic version of Lipitor in the US and seven other countries from November 2011.
Also found in: [+]
Ranbaxy, Pfizer pop peace pill 19.6.2008 Telegraph: Business
New Delhi, June 18: Ranbaxy Laboratories Ltd today sealed a deal with Pfizer Inc of the US to delay a copycat version of Lipitor ' the world's largest selling drug ' till November 2011, ending a patent dispute between the two drug companies that has raged for close to three years.
Also found in: [+]
Robots can cook and issue DDs too! 19.6.2008 Deccan Herald
Robots can cook and issue DDs too!
Also found in: [+]
Robots can cook and issue DDs too! 19.6.2008 Deccan Herald
Robots can cook and issue DDs too!
Also found in: [+]
Ranbaxy, Pfizer settle Lipitor dispute out of court 19.6.2008 Business Standard
Ranbaxy, Pfizer settle Lipitor dispute out of court
Also found in: [+]
Ranbaxy & Pfizer settle Lipitor patent lawsuits 19.6.2008 Financial Express
Ranbaxy & Pfizer settle Lipitor patent lawsuits
Also found in: [+]
Ranbaxy, Pfizer sign truce over Lipitor 19.6.2008 ET: Pharma

Ranbaxy has settled most of its patent disputes with Pfizer, allowing it to launch a generic version of Lipitor from November 30, 2011. Ranbaxy sell-off

Also found in: [+]
India not ready for a 'trip' on bio-piracy issues 19.6.2008 ET: Policy
India’s fight for tightening the Trips Agreement to check bio-piracy is slowly gaining support from more World Trade Organisation (WTO) member countries.
Also found in: [+]
Ranbaxy, Pfizer settle patent litigation over Lipitor 19.6.2008 New Indian Express
Ranbaxy, Pfizer settle patent litigation over Lipitor
Also found in: [+]
Pfizer, Ranbaxy settle Lipitor spat 19.6.2008 DNA: Money
Ending their five year battle in courts across the world, drug major Pfizer Inc, and Ranbaxy Laboratories Ltd, have settled on the former's blockbuster cholesterol drug Lipitor.
Also found in: [+]
Indian generic companies may tread Ranbaxy path 19.6.2008 ET: Pharma
Ranbaxy's patent settlement with Pfizer may lead more Indian generic cos to go for out-of-court settlements with their innovator counterparts.
Also found in: [+]
Ranbaxy & Pfizer settle Lipitor patent lawsuits 18.6.2008 Financial Express: Front Page
Close on the heels of the promoters selling 34.6% in Ranbaxy Laboratories for close to Rs 10,000 crore to Japanese pharma major Daiichi Sankyo, CEO & MD Malvinder Mohan Singh sprung another surprise by entering into an agreement with Pfizer Inc to settle most of their patent litigations worldwide involving atorvastatin, the world's largest selling drug with worldwide sales of $12.7 billion in 2007.
Also found in: [+]
7,454 to 7,473 of 9,592